POWER UP: Participating Online While Exercising to Recover Using Play
Exercise, Central Nervous System Tumors, Tumors
About this trial
This is an interventional supportive care trial for Exercise
Eligibility Criteria
Inclusion Criteria:
In order to be eligible to participate in Aim 1 of this study, an individual must meet all of the following criteria:
Round 1 focus groups:
- Oncologists who are caring for AYA cancer survivors or
- Survivorship care providers who actively engage with AYA cancer survivors
Round 2 focus groups:
- AYA cancer survivors age 15-39 years old
- Self-reported diagnosis of a primary benign or malignant CNS tumor or confirmed diagnosis of primary benign or malignant CNS tumor radiographically or pathologically when available
- ≤1-year post surgery and can have other tumor-directed treatment (e.g., radiation and/or chemotherapy)
- Participants and/or guardians are willing and able to provide informed consent
- Able to speak, read, and understand English
- Daily access to the web
- Can receive physical therapy because this is part of the standard of care
In order to be eligible to participate in Aim 2 of this study, an individual must meet all of the following criteria:
- Age 15-39 years old
- Self-reported diagnosis of a primary benign or malignant CNS tumor or confirmed diagnosis of primary benign or malignant CNS tumor radiographically or pathologically when available
- ≤1-year post surgery and can have other tumor-directed treatment (e.g., radiation and/or chemotherapy)
- Participant is insufficiently active (reports less than 150 minutes of planned moderate-vigorous intensity activity per week in the prior week)
- Able to speak, read, and understand English
- Daily access to the web
- Approval to participate from the oncology care team
- Participants and/or guardians are willing and able to provide informed consent
- Able to move arms and legs as well as ambulate safely with and without a gait aid
- Available space on the smartphone to download required apps
- Can receive physical therapy because this is part of the standard of care
- Participants and/or guardians are willing and able to provide informed consent for protocol PA18-0130 (Pediatric Energy Balance Data Repository Study), companion protocol for the Fitbit application/assessment.
Exclusion Criteria
An individual who meets any of the following criteria will be excluded from participation in Aim 1 of this study:
Round 1 Focus Groups:
1. Do not have access to the internet
Round 2 Focus Groups:
- Another member of the household is a participant or staff member on this trial
- Do not have access to the internet
- In foster care or is incarcerated
- Cognitive and/or major sensory deficits that would impede the completion of research activities and assessments as deemed by the clinical team.
- Self-reported diagnosis of a metastatic CNS tumor or confirmed diagnosis of a metastatic CNS tumor radiographically or pathologically when available
An individual who meets any of the following criteria will be excluded from participation in Aim 2 of this study:
- Currently pregnant
- Currently have dementia
- Plans to travel for more than 2 weeks at a time during the study period where the participant is not able to sign in to join the videoconferencing sessions
- Clinical judgment by the oncology care team concerning safety based on the Physical Activity Readiness Questionnaire for Everyone (2020 PAR-Q+)
- Cognitive and/or major sensory deficits that would impede the completion of research activities and assessments as deemed by the clinical team.
- Self-reported diagnosis of a metastatic CNS tumor or confirmed diagnosis of a metastatic CNS tumor radiographically or pathologically when available
- Currently participating in an organized commercial or research-based exercise program
- Another member of the household is a participant or staff member on this trial
Sites / Locations
- M D Anderson Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
Aim 1. Focus Groups
Aim 2. Pilot randomized controlled trial:
Healthcare providers (n=16-24 participants in 4 focus groups) from MD Anderson Cancer Center (MDACC). AYAs with primary benign or malignant central nervous system tumors (n=16-24 participants in 4 focus groups) treated at MDACC.
AYAs with primary benign or malignant central nervous system tumors (n=80 patients approached, with n= 40 participants consented and randomized to the intervention (n=20) or usual care control group (n=20)) treated at MDACC, any gender and race, who are ≤1-year post-surgery for a central nervous system tumor.